GCP

A Comprehensive Guide to Conducting In-Trial Patient Interviews

September 16, 2026

Plan Patient Interviews to Strengthen Trial Data Readiness

June 15, 2026

Designing Risk-Based QA Oversight for Clinical Trials Under ICH E6 (R3)

April 27, 2026

ICH GCP E6(R3): Preparing for global implementation, assessing the impact, risk and requirements of the change

December 16, 2025

ICH GCP E6(R3): Navigating the New Era of Good Clinical Practice

October 24, 2025

The Future of Clinical Research: Leveraging ICH E6(R3) Updates and Technology Innovation for Success

April 08, 2025

GCP ICH E6 R3 Unveiled: Navigating the Evolving Roles of Sponsors and CROs

March 28, 2025

Inspection Readiness and the Updated ICH E6 R3: What to Anticipate

December 12, 2024

How Oncology Biotechs Can Achieve Always Audit Ready Clinical Operations

November 26, 2024

From Past to Future: Using Experience to Enhance Clinical Trial Protocols

July 09, 2024

Inspection Readiness: What is it, why it matters, and what you need to know to be prepared

June 16, 2022

Implementing Risk-Based Quality Management (RBQM) – Lessons Learned and Key Pathways to Compliance

June 06, 2019

Quality Tolerance Limits as Required by ICH E6(R2): Definitions and Requirements for “Fit-For-Purpose” Compliance

January 09, 2019
Biotech Blogs

Preparing for ICH-GCP E6(R2): A Former GCP Inspector Answers Your Compliance Questions